IQ EQ Fund Management’s 10x Genomics TXG Stock Holding History

IQ EQ Fund Management’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.5M	Sell	404,351 -138,406	-26%	-$3.63M	0.99%	27
2026 Q1	$11.5M	Sell	542,757 -89,322	-14%	-$1.79M	0.88%	30
2025 Q4	$10.3M	Buy	632,079 +152,751	+32%	+$2.31M	0.71%	40
2025 Q3	$5.6M	Buy	479,328 +190,059	+66%	+$2.48M	0.38%	75
2025 Q2	$3.35M	Buy	289,269 +184,757	+177%	+$1.68M	0.3%	93
2025 Q1	$912K	Buy	104,512 +51,725	+98%	+$652K	0.11%	187
2024 Q4	$758K	Buy	52,787 +32,555	+161%	+$514K	0.09%	217
2024 Q3	$457K	Buy	20,232 +9,151	+83%	+$189K	0.05%	266
2024 Q2	$216K	Buy	+11,081	New	+$290K	0.02%	290

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IQ EQ Fund Management's TXG Position: Q2 2026 in Review

IQ EQ Fund Management reduced its 10x Genomics (TXG) stake by 26% in Q2 2026, selling an estimated $3.63M and leaving 404,351 shares worth $15.5M. The position accounts for 0.99% of the portfolio, ranked #27.

IQ EQ Fund Management first reported a position in TXG in Q2 2024 and has held it in 9 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

IQ EQ Fund Management held 404,351 shares of 10x Genomics worth $15.5M as of Q2 2026.
IQ EQ Fund Management sold 138,406 10x Genomics shares in Q2 2026, an estimated $3.63M.
10x Genomics made up 0.99% of IQ EQ Fund Management's portfolio in Q2 2026, its #27 holding.
IQ EQ Fund Management first reported a position in 10x Genomics in Q2 2024 and has held it in 9 quarters since.
392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on IQ EQ Fund Management's 13F filing for Q2 2026, filed 31 Jul 2026.